当前位置:首页 >> 农林牧渔 >>


China Integrated Programs for Research on AIDS (China CIPRA)
美国国立卫生研究院国际综合性艾滋病研究计划资助 Comprehensive International Program of Research on AIDS


Outline of China CIPRA
? CIPRA: Comprehensive International Program of Research on AIDS ? Sponsor: National Institute of Health, USA ? Corporation: National Center for STD/AIDS prevention and control, China CDC ? Period: July 1, 2002 to June 30, 2007 ? Budget: $15 millions ? Project provinces: Shanxi and Yunnan

Overall Goal
? To strengthen the existing HIV/AIDS research infrastructure in China and build the capacity to conduct multidisciplinary research to explore promising strategies for HIV/AIDS prevention, treatment and control.


Research Group
? The China CIPRA project is composed of 143 research staffs and 12 international consultants. ? The China CIPRA team is composed of 24 collaborating organizations including 13 domestic research institutes, 2 universities, and 2 hospitals, as well as 5 international universities and 2 research institutions.

Research Activity (I)
1. To estimate the prevalence and incidence of HIV-1 infection and to determine risk factors. 2. To evaluate the efficacy of more intensive, theoretically-based HIV skill-focused interventions for HIV+ adults. 3. To study viral and host factors that correlate with transmission of infection and factors that determine disease progression; and identify the immunodominant CTL epitopes and their MHC restricting elements in the most prevalent Chinese HIV subtypes as well as provide reagents for these studies. 5

Research Activity (II) 4. To characterize the clinical presentations of AIDS patients in China, to conduct clinical trials of antiviral drugs; 5. To develop vaccine candidates based on the Chinese prevalent strains and to conduct Phase I and Phase II clinical trials to evaluate its safety, immunogenicity and preliminary efficacy.


Research Team of China CIPRA
P I : Yiming Shao Co-PI : Dexian Zheng , Zunyou Wu Advisor: Yi Zeng

Core A (Administration and training)
Leader: Yiming Shao Co-Leader: Dexian Zheng Zunyou Wu Xiaoyan Zhang

Core B
(Statistical and Data Management) Leader: ShuiGao Jin Co-Leader: Hui Li Yuhua Ruan Consultant: Steve Self

Core C (Central Laboratory)
Leader: Yan Jiang Co-Leader: DeXian Zheng Consultant: Haynes W. Sheppard Huyen Cao

Core D (Primate)
Leader: Fude Fang Co-Leader: QiHan Li XinMing Tu Consultant: Ruth Ruprecht, Harold M.McClure, Xiaofang Yu

Project 1 (Epidemiology)
Leader: Xiwen Zheng Co-Leader: Zunyou Wu Lü Fan Shenghan Lai

Project 2 (Behaviroal Intervention)
Leader: Zunyou Wu Co-Leader and Consultant: Roger Detels Rotheram-Borus Mary Jane

Project 3
(Viral Immune Corrlates of
Transmission and Progression)

Project 4 (Clinical Research)
Leader: Yunzhen Cao Co-Leader: Taisheng Li Linqi Zhang Xiaoping Chen Consultant: David Ho

Project 5
(Development of a novel vaccine against HIV/AIDS in China) Leader: Li Ruan Co-Leader: Yiming Shao Wei He Yichen Lu Xiaofang Yu

Consultant: Sten Vermund
Roger Detels , ShenhanLai

Leader: Yiming Shao Co-Leader: Yunqi Geng Judy Lieberman Kunxue Hong , Xing Hui Consultant: Haynes W.Sheppard Huyen Cao


CIPRA Coordinating Committee(CCC) ( )
? The CCC is responsible for supervising the general research direction according to the goals of Chinese AIDS control and prevention effort. It will provide guidance and support for the implementation of the China CIPRA research protocol and schedule. In addition, the committee will translate the experiences and results of the China CIPRA program to help advance AIDS research throughout the country.

Scientific Advisory Board (SAB)
? Made up of independent domestic and international experts who are not affiliated with the research team. ? Responsibilities include:
assisting with the planning and implementation of the research protocol; receiving research progress reports on a regular basis; aiding in the resolution of research difficulties encountered; providing an independent assessment on a regular basis of the current status of research project


Monitoring Group on Quality Control (MGQC)
? This committee is composed of Chinese and international experts and is in charge of maintaining the quality of data generated from this project. The main responsibility of this group is to supervise the quality of the study based on the overall aims and goals of the China CIPRA plan. They will oversee quality control in the following areas: epidemiology, laboratory techniques, experiment quality, clinical studies, and particular research related to the GCP standards. This group will also evaluate the appropriateness of the consent forms and any pertinent ethical issues. They will scrutinize and provide feedback to the researchers to assure the future quality of the research.


Network of China-CIPRA Operational Systems
National Institutes of Health (NIH)

CIPRA Coordinating Committee (CCC)

CIPRA Executive Committee (CEC)

Scientific Advisory Board (SAB)

Study Plan/Protocol Ethic Committee (EC)

Study Implementation (Project and Core Activities) Community Advisory Board(CAB) Monitoring Group on Quality Control (MGQC)

Supervision Action


Study Population


Summary of Progress
? ? ? ? ? Set up the administration structure and research team; Conducted preparation work at Shanxi local sites; Developed research protocols; Created SOPs for CIPRA team (on going); Organized training according to the plan;IRB, GCP, management, research techniques, etc. Some researchers were trained oversea ? Strengthened communication among projects and cores, and communication with international organizations. Created web site and newsletter (electronic/paper version).

Training Information Welcome
? ? ? ? Project Management and Coordination Leadership and Organization 2 to 3 month/course advanced course preferred


Contact information
Address: 4 Nan Wei Road, Room 510 Xuan Wu District Beijing, China 100050 Tel: 86-10-63045970; ; 63015577 ex. 6510 Fax: 86-10-63045970 E-mail: cipracn@public3.bta.net.cn Website: http://www.chinaids.org.cn/cipra



要闻 中国全球基金艾滋病项目总结会纪要 2009 年 11 月 22~23 日,由中国疾病预防控制中心主办,中国疾病预防控 制中心性病艾滋病预防控制中心(NCAIDS)和上海市疾...
逃逸研究 艾滋病免疫抑制疗法 和根治策略研究 课题责任单位 中国疾病预防控制中心...性相关肝癌术后转 移复发的预测诊断与精 准防治 病毒性肝炎相关肝癌外 科综合...
研究机构和非政府组织的伙伴合作力度,开展综合艾滋病防治活动,全方位 协助中国...活动 内容涉及艾滋病治疗的临床研究和公共及社区防治教育项目等。例如,葛兰素史 ...
中国艾滋病现状_军事/政治_人文社科_专业资料。中国艾滋病现状艾滋病,获得性免疫缺陷综合症,是一种由人类免疫缺乏病毒的 反转录病毒感染后,因免疫系统受到破坏,逐渐...
性传播已成为艾滋病中国传播的主要途径, 2011 ...慢慢在中美项目、全球基金、美国开放社会研究所、香 ...这个提议最终就变成了一个综合化的同伴教育项目方案...
2004 年中国居民艾滋病常识及态度 和行为状况研究报告 北京零点指标信息咨询有限责任公司 2004 年 6 月 本项目研究结果专属中华人民共和国卫生部 中华人民共和国卫生...
中国性病艾滋病防治协会“艾伯维妇幼关爱及预防母婴传播基金”申请书 - 附件 3 中国性病艾滋病防治协会 “艾伯维妇幼关爱及预防母婴传播基金” 申请书 项目名称: ...
艾滋病综合防治示范区基线调查 实施方案 中国疾病预防控制中心 性病艾滋病预防控制中心 艾滋病综合防治示范区项目组 2003 年 5 月 1 艾滋病综合防治示范区基线调查...
“获得性免疫缺陷综合征”组配所有 副主题词共检索...Pubmed 收录的中国大陆文献数量为 213 篇,占艾滋病...动员项目 28 项资助,协助政府开展了大量的调查研究...